Truist Financial Corp Procept Bio Robotics Corp Transaction History
Truist Financial Corp
- $71.8 Billion
- Q3 2025
A detailed history of Truist Financial Corp transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Truist Financial Corp holds 7,171 shares of PRCT stock, worth $228,898. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,171Holding current value
$228,898% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
281Shares Held
45.2MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.21MShares$166 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$111 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$68.8 Million0.04% of portfolio
-
Chicago Capital, LLC1.57MShares$50.1 Million1.39% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$48.8 Million0.06% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.42B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...